Swanson, G. M.
Nassan, F. L.
Ford, J. B.
Hauser, R.
Pilsner, J. R.
Krawetz, S. A.
Funding for this research was provided by:
National Institutes of Health (ES017285, ES017285)
Article History
Received: 19 September 2022
Accepted: 13 December 2022
First Online: 24 January 2023
Declarations
:
: The semen samples were collected, processed, and analyzed at Wayne State University under the IRB protocols H-06-67-96 and HIC 095701MP2F.
: Not applicable.
: The authors declare no competing financial interests but the following competing interest. FLN is a current employee and a shareholder of Biogen, Cambridge, MA. The original work on MARS Study (2 arm study) at Harvard T. H. Chan School of Public Health (HSPH), however, pre-dated the current employment. This manuscript does not mention any Biogen products or any of the disease states that Biogen is actively doing research in (to the coauthor’s knowledge). The authors declare no non-financial competing interests.